MF
STOK icon

Magnetar Financial’s Stoke Therapeutics STOK Stock Holding History

Magnetar Financial’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205K Buy
+6,270
New +$201K ﹤0.01% 932

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Magnetar Financial's STOK Position: Q2 2026 in Review

Magnetar Financial opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 6,270 shares worth $205K. The stake represents ﹤0.01% of the portfolio and ranks #932 among its holdings.

198 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Magnetar Financial held 6,270 shares of Stoke Therapeutics worth $205K as of Q2 2026.
  • Stoke Therapeutics was a new Magnetar Financial position in Q2 2026.
  • Stoke Therapeutics made up ﹤0.01% of Magnetar Financial's portfolio in Q2 2026, its #932 holding.
  • 198 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.